Bruce A Perkins
Overview
Explore the profile of Bruce A Perkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
222
Citations
6436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sridhar V, Kugathasan L, Lovblom L, Huajing N, Lanctot S, Maahs D, et al.
J Am Soc Nephrol
. 2025 Feb;
PMID: 39982799
No abstract available.
2.
Bapat P, Budhram D, Bakhsh A, Abuabat M, Verhoeff N, Mumford D, et al.
Diabetes Care
. 2025 Feb;
PMID: 39950992
Objective: We aimed to determine whether diabetes complications, such as kidney disease that may impair acid-base buffering capacity, independently predict the risk of subsequent diabetic ketoacidosis (DKA). Research Design And...
3.
Nardone M, Kugathasan L, Sridhar V, Dutta P, Campbell D, Layton A, et al.
Clin J Am Soc Nephrol
. 2025 Feb;
PMID: 39918875
No abstract available.
4.
Raudanskis A, Sarma S, Biering-Sorensen T, Zorcic K, Razak F, Verma A, et al.
J Diabetes Complications
. 2024 Dec;
39(2):108945.
PMID: 39740304
Aims: To identify factors associated with use of novel diabetes medications among patients hospitalized under general internal medicine. Methods: We conducted a cohort study of patients with type 2 diabetes...
5.
Perkins B, Turner L, Riddell M
Diabetologia
. 2024 Dec;
68(2):474.
PMID: 39661120
No abstract available.
6.
Idiaquez J, Barnett-Tapia C, Perkins B, Bril V
J Peripher Nerv Syst
. 2024 Nov;
29(4):400-405.
PMID: 39532698
Background And Aims: Small-fibre neuropathy (SFN) is associated with glucose dysregulation, including impaired glucose tolerance (IGT) and type 2 diabetes (T2D). Corneal confocal microscopy (CCM) offers a non-invasive tool to...
7.
Ray P, Moggridge J, Weisman A, Tadrous M, Drucker D, Perkins B, et al.
Can J Diabetes
. 2024 Nov;
PMID: 39486576
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective medications for type 2 diabetes mellitus (T2DM) and obesity, yet their uptake among patients most likely to benefit has been slow. Methods:...
8.
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades
Budhram D, Bapat P, Bakhsh A, Abuabat M, Verhoeff N, Mumford D, et al.
Diabetes Technol Ther
. 2024 Oct;
27(2):139-143.
PMID: 39387222
Continuous subcutaneous insulin infusion (CSII) in type 1 diabetes has been regarded as a major diabetic ketoacidosis (DKA) risk factor. We aimed to determine secular trends in risk since CSII...
9.
Perkins B, Turner L, Riddell M
Diabetologia
. 2024 Aug;
67(10):2045-2058.
PMID: 39145882
Challenges and fears related to managing glucose levels around planned and spontaneous exercise affect outcomes and quality of life in people living with type 1 diabetes. Advances in technology, including...
10.
Budhram D, Bapat P, Bakhsh A, Abuabat M, Verhoeff N, Mumford D, et al.
Can J Diabetes
. 2024 Jul;
48(7):462-470.e3.
PMID: 39069232
Objectives: Diabetic ketoacidosis (DKA) occurring after diabetes diagnosis is often associated with risk factors for other diabetes-related complications. In this study, we aimed to determine the prognostic implications of DKA...